CELC Hisse Senedi Fiyat Grafiği
CELC Hisse Fiyat Tahmini
Celcuity Inc
$125.65
3.54%
$4.3
Kapanışta: May 01, 16:00:00 GMT-4
$143
13.8%
$17.34
Sonrası Piyasa: May 01, 20:00:00 GMT-4
Geri
Celcuity Inc (CELC) Hisse Fiyat Tahmini
Önemli İstatistikler
Önceki Kapanış
$121.35
Açılış fiyatı
$121.02
Günün Aralığı
$117.49 - $143
52 haftalık aralık
$8.53 - $143
İşlem hacmi
1.8M
Ort.Hacim
756.6K
Dividend yield
--
EPS (TTM)
-3.78
Piyasa Değeri
$6.9B
CELC nedir?
Celcuity, Inc. operates as a cellular analysis company. The company is headquartered in Minneapolis, Minnesota and currently employs 87 full-time employees. The company went IPO on 2017-09-20. Its lead therapeutic candidate is gedatolisib, a potent, small-molecule reversible inhibitor that selectively targets all Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2. Its development programs for gedatolisib focus on the treatment of patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), or HR+/HER2-, advanced or metastatic breast cancer and patients with metastatic castration resistant prostate cancer. A Phase III clinical trial of VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast has commenced. Its CELsignia companion diagnostic platform is able to analyze live patient tumor cells.
